萝莉社

(904) 244-0411 Education Research Community

Treats Adults

Michael D Schweitzer Barrios, MD

Pulmonologist, Critical Care Medicine Physician

Request appointment online

Research at a glance

Research activity

24 publications

0 citations

Why is this important?

Active clinical trials

Phase III, randomized, double-blind, placebo-controlled study to assess BI 1291583 2.5 mg once daily for up to 76 weeks in patients with bronchiectasis

Investigator: Michael D Schweitzer Barrios
Status: Accepting Candidates
Ages: 18 Years - 99 Years
Sexes: All

Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY)

Investigator: Michael D Schweitzer Barrios
Status: Accepting Candidates
Ages: 40 Years - 80 Years
Sexes: All

My publications

24 publications

2025

When Nodules Play Tricks: A Fungus Among Us Mimicking Lung Cancer

American Journal of Respiratory and Critical Care Medicine

2024

A FLUID SITUATION: A RARE CASE OF LEFT-SIDED CHYLOTHORAX

CHEST

2024

HIDING IN PLAIN SITE: ARDS IN THE SETTING OF SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA WITH SECONDARY HEMOPHAGOCYTIC SYNDROME

CHEST

2024

Interstitial Lung Disease as an Emerging Contributor to Mortality in Patients With Inflammatory Bowel Disease: A Population-Based Epidemiological Study

Clinical and Translational Gastroenterology

2024

Alpha-1 Anti-Trypsin Carrier Genotype and the Risk of COPD Exacerbations: A Methodological Abstract

B50. EMERGING RESEARCH IN ALPHA-1-ANTITRYPSIN DEFICIENCY